Rosetta Genomics Ltd
OTC:ROSGQ
Rosetta Genomics Ltd
Pre-Tax Income
Rosetta Genomics Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Rosetta Genomics Ltd
OTC:ROSGQ
|
Pre-Tax Income
-$16.3m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Pre-Tax Income
-$7m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Pre-Tax Income
$8.4m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
33%
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Pre-Tax Income
-$98.3m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Pre-Tax Income
-$8.9m
|
CAGR 3-Years
8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Pre-Tax Income
-₪31m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-12%
|
See Also
What is Rosetta Genomics Ltd's Pre-Tax Income?
Pre-Tax Income
-16.3m
USD
Based on the financial report for Dec 31, 2016, Rosetta Genomics Ltd's Pre-Tax Income amounts to -16.3m USD.
What is Rosetta Genomics Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-17%
Over the last year, the Pre-Tax Income growth was 6%. The average annual Pre-Tax Income growth rates for Rosetta Genomics Ltd have been -7% over the past three years , -17% over the past five years .